Update for investors of $HONASA

$HONASA is currently trading at Rs. 418.85, up by 2.40 points or 0.58% from its previous closing of Rs. 416.45 on the BSE. The scrip opened at Rs. 419.20 and has touched a high and low of Rs. 434.95 and Rs. 416.45 respectively. So far 1289844 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 437.90 on 11-Jun-2026 and a 52 week low of Rs. 248.55 on 11-Dec-2025. Last one week high and low of the scrip stood at Rs. 434.95 and Rs. 402.35 respectively. The current market cap of the company is Rs. 13812.02 crore. The promoters holding in the company stood at 35.54%, while Institutions and Non-Institutions held 32.98% and 31.48% respectively. This strategic acquisition marks Honasa's entry into the high-growth nutraceuticals space, reinforcing its commitment to building science-backed solutions that address evolving consumer needs across ‘inside-out’ beauty. Through this acquisition, Honasa Consumer will execute its entry into the category by establishing its dedicated subsidiary, Honasa Health. Under this new entity, the company will scale a highly differentiated B2C nutrition portfolio by combining Fluence’s patented clinical science and deep practitioner trust with its own expertise in brand building, consumer insights, and digital-first distribution. The board of directors of the company at its meeting held on June 23, 2026 approved the same. Honasa Consumer, doing business as Mamaearth, provides e-commerce services. The company offers baby, skin, body, and hair care products, as well as mosquito protection roll on and creams.